60 Degrees Pharmaceuticals (SXTP) Research & Development (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) reported Research & Development of $598,653 for Q2 2026, up 158.1% from $231,912 a year earlier and up 112.7% from the prior quarter.
Powered by 
Analysis
60 Degrees Pharmaceuticals (SXTP) Research & Development (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 60 Degrees Pharmaceuticals' Research & Development came in at $2.33 million, up 8.0% year-over-year; for FY2025, it was $2.11 million, down 57.8% from FY2024.
- Research & Development has a three-year compound annual growth rate of 58.8% (FY2022 to FY2025).
- By year, Research & Development came in at $4.99 million in FY2024 (+620.8%), $691,770 in FY2023 (+31.6%) and $525,563 in FY2022.
- Five-year quarterly Research & Development spans a low of $27,655 in Q3 2022 and a high of $3.1 million in Q2 2024.
- Year over year, Research & Development gained in five of the last eight quarters, with growth averaging 101.4%.
- The high point for year-over-year Research & Development in five years was Q3 2023 (growth of 853.5%); the low point was Q2 2025 (a decline of 92.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $281,464 (Q1 2026), $638,873 (Q4 2025) and $809,777 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.54 Mn | 2.43 Mn | 56,798.00 | 598,653.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 598,653.00 |
| Mar 31, 2026 | 281,464.00 |
| Dec 31, 2025 | 638,873.00 |
| Sep 30, 2025 | 809,777.00 |
| Jun 30, 2025 | 231,912.00 |
| Mar 31, 2025 | 370,813.00 |
| Dec 31, 2024 | 613,955.00 |
| Sep 30, 2024 | 940,063.00 |
| Jun 30, 2024 | 3.10 Mn |
| Mar 31, 2024 | 337,182.00 |
| Dec 31, 2023 | 100,201.00 |
| Sep 30, 2023 | 263,703.00 |
| Jun 30, 2023 | 203,872.00 |
| Mar 31, 2023 | 123,994.00 |
| Dec 31, 2022 | 203,457.00 |
| Sep 30, 2022 | 27,655.00 |
| Jun 30, 2022 | 231,394.00 |
API Access
60 Degrees Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SXTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SXTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SXTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();